---
category: news
title: "LLY, CVS, EXAS: Which Strong-Buy-Rated Healthcare Stock Is the Better Buy?"
excerpt: "The rise of GLP-1 weight-loss drugs has arguably been the second-hottest trend in the stock market right now â€” second to generative artificial"
publishedDateTime: 2024-02-20T04:39:00Z
originalUrl: "https://markets.businessinsider.com/news/stocks/lly-cvs-exas-which-strong-buy-rated-healthcare-stock-is-the-better-buy-1033081825"
webUrl: "https://markets.businessinsider.com/news/stocks/lly-cvs-exas-which-strong-buy-rated-healthcare-stock-is-the-better-buy-1033081825"
type: article
quality: 67
heat: 67
published: false

provider:
  name: Business Insider
  domain: businessinsider.com
  images:
    - url: "https://everyday-cc.github.io/ai/assets/images/organizations/businessinsider.com-50x50.jpg"
      width: 50
      height: 50

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://blog.tipranks.com/wp-content/uploads/2024/02/image-446-1024x342.png?utm_source=markets.businessinsider.com&utm_medium=referral"
    width: 1024
    height: 342
    isCached: true

secured: "tU91zpFLz6F/M5S+23E44Gs1Hhe5tOh+sK/jdQkkP01qPRyqKItCb+c9PGBxqTYYTth59MJOlVBfRzaQ/ujHOeBh1ERGnCf4Bu0tuuyC4FSGs9I2UC/oEImeOMIeXVmHE/eEbLWBzDOTIMW6o/Z/N5fmKxgSuqYFwUg8U67/+loxFrYzPmHGghHxeVzvOSg8n4Ms0FQUarNg6hS5j0Vn+5yxgARurfPYY5OhscWG4+uGO2MiI4KdjZkrrkqgF6RKmuKDWD8cIiDmu+F8QKuZLgxm7yCw1PHhZzwGMAyCLMWNeE+NJbmw6Rq90XYg0dp23fdjPy4mW1x/wVXRX+FTOuNSVu3r5Z7pQdDAcTL89lM=;0js0I/KXcE8g3WSTHxjoRA=="
---

